. 2020 Jul 30;52(9):2676–2683. doi: 10.1016/j.transproceed.2020.07.012

Table 3.

Duration Since Transplantation and Mortality in Liver Transplant Recipients With COVID-19

	Overall^† (N = 203)	Deceased^∗ (n = 43)	Survived (n = 160)	P Value
Duration Since Transplant
< 2 y since transplant (%)	14.7 (n = 30)	11.6 (n = 5)	15.6 (n = 25)	.51
> 2 y since transplant (%)	85.2 (n = 173)	23.8 (n = 38)	84.4 (n = 135)	.51

Abbreviation: COVID-19, coronavirus disease 2019.

^∗

Data from Belli et al [15] reported overall outcomes, and did not stratify comorbidities, symptoms on presentation and immunosuppression used based on mortality.

^†

Data from Pereira et al [9] with severe disease - defined as ICU admission, intubation or death’, were presumed deceased in this analysis. (n = 4).